NY-based startup Heartbeat Health raises US$ 20M in Series B

NY-based Heartbeat Health, a healthcare company working to deliver the most effective, efficient, and engaging heart care, raised US$ 20 million in a Series B funding round on 10 May 2021.

Investors: The funding round was led by Echo Health Ventures, with participation from DaVita Venture Group and existing investors, .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures.

Purpose of the funding: The funds raised will be utilized by the startup to accelerate it product research and development as well as expand clinical services to at-risk organizations.

About Heartbeat Health

Founded in 2017 by Jeffrey Wessler and Nayan Jain, Heartbeat Health has developed an experience to screen, diagnose, track and manage cardiovascular risk and disease to keep people at their healthiest. Heartbeat claims to have delivered care to more than 20,000 patients nationwide.

Its mission is to fundamentally reshape cardiovascular care to address heart disease, one of the most expensive and deadly diseases. Heartbeat offers virtual-first cardiovascular disease prevention and management with a focus on improved clinical experience, health outcomes, and reduced costs. The Heartbeat virtual-first platform combines telemedicine, diagnostic coordination, medication management, lifestyle guidance and stakeholder engagement to offer a data-powered patient and provider experience

What the CEO has to say: “We’ve built a remarkable virtual-first platform to standardize and scale cardiovascular care for patients who need it the most. By working with at-risk organizations our model has focused on improving clinical outcomes at lower costs and provides a much-needed data-driven approach to this growing field of virtual care.” — Dr. Jeff Wessler, cardiologist and co-founder and CEO of Heartbeat Health

About Echo Health Ventures

Echo Health Ventures aims to support the systemic health care transformation through its purpose-driven and strategic venture capital and growth equity investments. Echo’s portfolio includes USAble Corporation, Cambia Health Solutions and Mosaic Health Solutions. The Venture firm supports those companies that aim to accelerate health care innovation on a national scale.

What the investors have to say: “From the beginning, Heartbeat focused on evidence-based care, patient outcomes, cost-effectiveness, and clinical tools for cardiologists built by cardiologists. With this focus, they have already emerged as a market leader in a new model of patient-focused care for heart health. Echo Health Ventures looks forward to partnering with Heartbeat Health to address the critical issues of cardiovascular disease prevention and management through Heartbeat’s platform and a new model of value-based care.” — Jessica Zeaske, Partner at Echo Health Ventures who will join the Board of Directors at Heartbeat. 

We try our best to fact check and bring the best, well-researched and non-plagiarized content to you. Please let us know

-if there are any discrepancies in any of our published stories,

-how we can improve,

-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!

Next Article